Topic: academic partnership
Takeda has added another early-stage research partnership as it reboots its R&D operations, this time teaming with two Seattle-based academic centers.
Pfizer has set up a new partnering network to try to foster collaborations with top-tier universities
Novartis and UC Berkeley have formed a pact to unlock difficult drug targets and boost development of new meds in infectious diseases and cancer.
Australian scientists have found a natural compound in seaweed that can halt inflammation after traumatic brain injury.
Erytech Pharma has formed a collaboration with Canada’s Queen’s University to advance its drug against the metabolic disorder arginase-1 deficiency.
Lilly and Purdue University have teamed up to work on a new research collaboration.
Merck KGaA has taken its oncology collaboration with Cancer Research Technology to the next level.
Takeda Pharmaceutical has teamed up with Harrington Discovery Institute to support research into treatments for rare diseases.